Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of Vincerx Pharma, Inc. for 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Vincerx Pharma, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate for 31 Mar 2024.
  • Vincerx Pharma, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Mar 2024 was $2,500,000,000.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)

Vincerx Pharma, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,500,000,000 31 Mar 2024 10-Q 14 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.